Abstract
No public abstract is available from the verified source records.
E.Nigel Harris, Silvia S Pierangeli
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Syndrome of the black swan
10.1093/rheumatology/26.5.324 · 1987
Towards improved criteria for the antiphospholipid syndrome
10.1177/096120339800700233 · 1998
The ‘primary’ antiphospholipid syndrome: major clinical and serological features
10.1097/00005792-198911000-00004 · 1989
Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus: a prospective analysis of 500 consecutive patients
10.1097/00005792-198911000-00003 · 1989
The ‘catastrophic’ antiphospholipid syndrome
1992
International consensus statement on preliminary classification for definite antiphospholipid syndrome
10.1002/1529-0131(199907)42:7<1309::aid-anr1>3.0.co;2-f · 1999
The second international anticardiolipin standardization workshop/the Kingston Antiphospholipid Antibody Study (KAPS) group
10.1093/ajcp/94.4.476 · 1990
Prevalence, significance, and specificity of antibodies to phospholipids in Q fever
10.1093/clinids/18.2.213 · 1984
Anticardiolipin antibodies associated with HTLV-III infection
10.1111/j.1365-2141.1987.tb04157.x · 1987
Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus
10.1002/art.1780400115 · 1997
High levels of antiphospholipid antibodies are associated with cytomegalovirus infection in unrelated bone marrow and cord blood allogeneic stem cell transplantation
10.1046/j.1365-2141.2000.01812.x · 2000
Autoantibodies directed against phospholipids or human β2-glycoprotein 1 in HIV-sero positive patients: relationship with endothelial activation and antimalonic dialdehyde antibodies
10.1046/j.1365-2362.1998.00254.x · 1998
Prevalence and significance of anticardiolipin, anti-β2-glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C
10.1046/j.1365-2141.1998.00722.x · 1998
Transverse myelitis: a manifestation of systemic lupus erythematosus with antiphospholipid antibodies: a review of 31 patients
1996
A comparison of cardiac valvular involvement in the primary antiphospholipid-anticardiolipoin-negative systemic lupus erythematosus
10.1016/0002-8703(93)90124-r · 1993
Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings
10.1177/096120339600500111 · 1996
Epidemiology of antiphospholipid antibody and vascular disease
1999
Anticardiolipin (ACA) antibodies directed not to cardiolipin but to a plasma protein cofactor
10.1016/0140-6736(90)91374-j · 1990
Anticardiolipin antibodies directed not to cardiolipin but to a plasma protein cofactor
1990
Anticardiolipin autoantibodies recognize β2-glycoprotein I in the absence of phospholipid: importance of antigen density and bivalent binding
10.4049/jimmunol.154.2.954 · 1995
A more specific ELISA assay for the detection of antiphospholipid
10.1016/0197-1859(95)80012-3 · 1995
Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with a variety of connective tissue diseases
1999
Comparison of three assays for the detection of antiphospholipid and anti-β2-glycoprotein 1 antibodies
1998
Autoantibodies to β2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid syndrome: clinical correlations in comparison with other antibody tests
1988
Anti beta glycoprotein 1 antibodies: detection and association with thrombosis
10.1111/j.1365-2141.1995.tb03317.x · 1995
Do antibodies to β2-glycoprotein I contribute to a better characterization of the antiphospholipid syndrome
1999
Reactivity to β2-glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis
10.1055/s-0038-1650354 · 1996
Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin
10.1055/s-0038-1646476 · 1991
Mechanism and effects of the binding of lupus anticoagulant IgG and prothrombin to surface phospholipids
10.1182/blood.v88.11.4173.bloodjournal88114173 · 1996
Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C or protein S: an explanation for their pathogenic mechanism?
10.1182/blood.v81.10.2618.2618 · 1993
Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody
10.1002/ajh.2830470112 · 1994
Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus
10.1016/s0002-9343(99)80014-x · 1995
Thrombosis, recurrent fetal loss and thrombocytopenia Predictive value of the anti-cardiolipin test
10.1001/archinte.1986.00360230069012 · 1986
IgA anticardiolipin antibodies—relation with other antiphospholipid antibodies and clincial significance
1988
Significance of IgA antiphospholipid antibodies
10.1177/096120339800700225 · 1998
No additional external references are available.